26 May 2023
Research presented at the European Congress on Obesity has identified a link between semaglutide, a common weight-loss drug, and a notable reduction in cardiovascular risks in patients with obesity after one year of use. The study concludes the importance of weight-loss in these improvements.
Study using twins sees cardiovascular improvements with vegan diet
07 Dec 2023
Menarche at early age linked to increased diabetes risk
07 Dec 2023
In utero exposure to Covid-19 associated with preterm birth
07 Dec 2023
Type 2 diabetes risk may be reduced with fast walking
01 Dec 2023
Pomegranate consumption linked to prevention of metabolic disorders
01 Dec 2023